Antiviral treatment reduces risk of liver cancer in people with hepatitis C-related cirrhosis and fibrosis
Bacterial translocation is associated with more severe liver fibrosis in HIV/hepatitis C-co-infected people
Insulin resistance is a big risk factor for the progression of liver fibrosis in HIV/HCV co-infected people
Doctors in Europe and the US disagree over the pace of liver fibrosis in men co-infected with HIV and hepatitis C
BI 201335 & BI 207127 and ribavirin shows good efficacy, including hepatitis C patients with cirrhosis
Brivanib did not improve overall liver cancer survival, but did show anti-tumour activity
![Josep Llovet, University of Barcelona [Photo by Liz Highleyman, hivandhepatitis.com]](https://ik.imagekit.io/ftwmbwg7i/tr:w-640,h-480,q-80,fo-auto,f-auto/https%3A%2F%2Fcdn.craft.cloud%2F019ecfe4-fa59-7378-875f-6ad629d65a81%2Fassets%2F2012-04%2Fbrivanib-did-not-improve-overall-liver-cancer-survival-but-did-show-anti-tumour-activity.jpg?ik-s=72da0bc390c58f9e219054c2b59b14a731faf359&ik-t=7552444800)
Liver fibrosis increases risk of discordance in CD4 cell count and percentage in HIV-positive people
Maraviroc improves liver fibrosis in HIV/hepatitis C co-infected patients
